Ionis Pharmaceuticals, Inc.: Guggenheim is no longer for sale








Marketzone with MT Newswires 2022

All the news about IONIS PHARMACEUTICALS, INC.

Analyst Recommendations for IONIS PHARMACEUTICALS, INC.

2022 turnover 613M
–
552M
2022 net result -344M
–
-310M
Net debt 2022 387M
–
349M
PER 2022-14.0x
2022 return–
Capitalization 4,829M
4,829M
4,344M
VE / CA 20228.51x
VE / CA 20238.30x
Number of employees660
Floating98.9%

Chart IONIS PHARMACEUTICALS, INC.


Tough :

Period:




Ionis Pharmaceuticals, Inc.: Ionis Pharmaceuticals, Inc. Technical Analysis Chart | Market area

Trends Technical Analysis IONIS PHARMACEUTICALS, INC.

Short termMiddle termLong term
TrendsbullishNeutralbearish

Evolution of the Income Statement

Sale

Purchase

Average recommendationACCUMULATE
Number of Analysts20
Last Closing Price

$34.08

Average price target

$50.50

Deviation / Average Target 48.2%

Officers and Directors




Source link -88